AUSTRALIA TO HOST CLINICAL TRIAL OF GENETICALLY MODIFIED NASAL SPRAY ADENOVIRUS VACCINE

Highlights:

• The government of Australia is all set for hosting the clinical trial of the genetically modified adenovirus nasal spray vaccine
• A contract research organisation has applied for the permission to conduct the phase one clinical trial of the nasal spray vaccine

Australia has now been all set for hosting the first human clinical trial of a genetically modified adenovirus ....